Local release of dexamethasone from polymer millirods effectively prevents fibrosis after radiofrequency ablation

Journal of Biomedical Materials Research - Part A

Volumn 76, Issue 1, 2006, Pages 174-182

  Blanco, Elvin ^a,c   Weinberg, Brent D ^a   Stowe, Nicholas T ^b   Anderson, James M ^b   Gao, Jinming ^a  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Dexamethasone; Fibrous capsule formation; Inflammation; Polymer implant; Radiofrequency ablation

Indexed keywords

ANIMAL CELL CULTURE; DRUG THERAPY; IMPLANTS (SURGICAL); TUMORS;

DEXAMETHASONE; INFLAMMATION; POLYMER IMPLANT; RADIOFREQUENCY ABLATION;

POLYMERS;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; DEXAMETHASONE; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TRANSPORT; INFLAMMATION; LIVER FIBROSIS; NONHUMAN; RADIOFREQUENCY ABLATION; RAT; TUMOR RECURRENCE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BETA-CYCLODEXTRINS; BIOCOMPATIBLE MATERIALS; CATHETER ABLATION; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; FIBROSIS; HUMANS; LACTIC ACID; LIVER; LIVER NEOPLASMS; MALE; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 30444459009     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30516     Document Type: Article

References (27)

1. Siperstein A, Garland A, Engle K, Rogers S, Berber E, String A, Foroutani A, Ryan T. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Surg Endosc 2000;14:400-405.
2. Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, et. al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003;38:977-981.
3. Takada Y, Kurata M, Ohkohchi N. Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma. Int J Clin Oncol 2003;8:332-335.
4. Kosari K, Gomes M, Hunter D, Hess DJ, Greeno E, Sielaff TD. Local, intrahepatic, and systemic recurrence patterns after radiofrequency ablation of hepatic malignancies. J Gastrointest Surg 2002;6:255-263.
5. Bathe O, Dowden S, Sutherland F, Dixon E, Butts C, Bigam D, et al. Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma. BMC Cancer 2004;4:32.
6. DiPetrillo T, Dupuy D. Radiofrequency ablation and radiotherapy: complementing treatments for solid tumors. Semin Interv Rad 2003;20:341-345.
7. Qian F, Szymanski A, Gao J. Fabrication and characterization of controlled release poly(D,L-lactide-co-glycolide) millirods. J Biomed Mater Res 2001;55:512-522.
8. Qian F, Stowe N, Saidel G, Gao J. Comparison of doxorubicin concentration profiles in radiofrequency-ablated rat livers from sustained- and dual-release PLGA Millirods. Pharm Res 2004;21:394-399.
9. Qian F, Stowe N, Liu E, Saidel G, Gao J. Quantification of in vivo doxorubicin transport from PLGA millirods in thermo-ablated rat livers. J Control Release 2003;91:157-166.
10. Blanco E, Qian F, Weinberg B, Stowe N, Anderson J, Gao J. Effect of fibrous capsule formation on doxorubicin distribution in radiofrequency ablated rat livers. J Biomed Mater Res 2004; 69:398-406.
11. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res 1997;37:401-412.
12. Hickey T, Kreutzer D, Burgess D, Moussy F. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res 2002;61:180-187.
13. Levy R, Labhasetwar V, Song C, Lerner E, Weiliam C, Vyavahare N, et. al. Polymeric drug delivery systems for treatment of cardiovascular calcification, arrhythmias and restenosis. J Control Release 1995;36:137-147.
14. Schimmer B, Parker K. Adrenocorticotropic hormone; adreno-cortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman J, Limbird L, Molinoff P, Ruddon R, Gilman A, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill; 1996. p 1459-1485.
15. Vianna R, Bentley M, Ribeiro G, Carvalho F, et al. Formation of cyclodextrin inclusion complexes with corticosteroids: their characterization and stability. Int J Pharm 1998;167:205-213.
16. Usayapant A, Iyer B. The effect of 2-hydroxypropyl-beta-cyclodextrin on in vitro drug release of steroids from suppository bases. Drug Dev Ind Pharm 1999;25:387-390.
17. Anderson J. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol 1993;2:33S-41S.
18. Dilova V, Zlatarova V, Spirova N, Filcheva K, Pavlova A, Grigorova P. Study of insolubility problems of dexamethasone and digoxin: cyclodextrin complexation. Boll Chim Farm 2004; 143:20-23.
19. Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci 2004;93:1804-1814.
20. Nimmo A, Carstairs J, Patole S, Whitehall J, Davidson K, Vink R. Intratracheal administration of glucocorticoids using surfactant as a vehicle. Clin Exp Pharmacol Physiol 2002;29:661-665.
21. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh D, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995;270:12607-12613.
22. Luo J, Shin V, Liu E, Ye Y, Wu W, So W, Chang F, Cho C. Dexamethasone delays ulcer healing by inhibition of angiogenesis in rat stomachs. Eur J Pharmacol 2004;485:275-281.
23. Nauck M, Karakiulakis G, Perruchoud A, Papakonstantinou E, Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998;341:309-315.
24. Wang JM, Deng X, Gong W, Su S. Chemokines and their role in tumor growth and metastasis. J Immunol Methods 1998;220:1-17.
25. Raz A, Levine G, Khomiak Y. Acute local inflammation potentiates tumor growth in mice. Cancer Lett 2000;148:115-120.
26. Coussens L, Werb Z. Inflammation and cancer. Nature 2002; 420:860-867.
27. Harrison L, Koneru B, Baramipour P, Fisher A, Barone A, Wilson D, Dela Torre A, Cho K, Contractor D, Korogodsky M. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2003;197:759-764.